RadiantInsights.com added Most up-to-date research on “United States Point-of-Care Testing (POCT) Devices Industry 2017 Market Research Report ” to its huge collection of research reports.

The U.S. point-of-care testing (POCT) devices market is expected to witness high growth over the forecast period (from 2017 to 2022). Point-of-care testing is a medical diagnostic test performed at the time and place of patient care.

Point-of-care tests are generally performed by a member of the non-laboratory staff and results of these tests can guide in clinical decision-making. The tests are commonly performed with the help of portable, handheld, and transportable instruments, such as blood glucose meter, along with various test kits.

Point-of-care testing devices are utilized to get diagnostic results and are used in hospitals, patients’ homes, and doctors’ offices. They provide fast feedback on many types of clinical tests. They are utilized for electrolyte and enzyme analysis, to check cholesterol and glucose levels, for pregnancy testing, and for infectious disease testing.

There are many benefits of POCT devices, such as faster results and, if required, quick implementation of treatments. Development of faster, cheaper, and smarter devices has augmented the usage of POCT. This has resulted in cost-effective testing for a variety of diseases, such as Carpal Tunnel Syndrome (CTS) and acute coronary syndrome. This is projected to increase product demand, thereby boosting overall market growth.

Factors such as rising cases of various diseases due to infections, changing lifestyles, and increasing inclination toward home healthcare in the U.S. region are responsible for the growth of this market. In addition, greater investments and venture funding for development of novel technologies and products and positive government support have encouraged the use of POCT devices across the globe.

Apart from these factors, increasing penetration of these testing devices in the U.S. region along with supportive reimbursement systems are attributable to the overall growth of the market. Strong presence of key industry participants in the United States is also anticipated to propel market growth.

Nanomix Inc. has developed a next-generation point-of-care testing device. It provides speedier and more precise results of sepsis compared to central lab tests, which might take hours to deliver test results. This new device can provide analysis for PCT, lactate, and C-Reactive protein to make sure a person has sepsis. This system includes a handheld reader and an assay cartridge with a biosensor based on carbon nanostructure.

The point-of-care testing devices market in U.S. is categorized as per product type, application or end user, and region. Based on product type, the market is segmented into hospital POCT equipment and home POCT equipment. Based on end user, the market is categorized into blood biochemical detection, urine detection, cardiovascular disease detection, pathogenic microorganism detection, tumor markers detection, and others. Based on region, the U.S. market is divided into the Mid-Atlantic states, Southwestern United States, New England, Southern United States, Midwestern United States, and Western United States.

Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.